KOMBIGLYZE - XR - New Type 2 Diabetes Medication Released
The FDA approved the new type 2 diabetes medication Kombiglyze - XR on November 5, 2010. It is now available by prescription in the United States. The medication comes in the form of a tablet and is taken once a day. It works well with a controlled diet and exercise program.
Kombiglyze - XR
Kombiglyze - XR is the first once a day metformin extended-release (XR) plus dipeptidyl peptidase-4 (DPP-4) inhibitor combination. in one tablet for the treatment of type 2 diabetes. KOMBIGLYZE XR should generally be administered once a day with the evening meal, with gradual dose titration to reduce the gastrointestinal side effects associated with metformin. The maximum daily recommended dose is 5 mg for saxagliptin and 2,000 mg for metformin extended-release.
Kombiglyze - XR is to be used for patients with type 2 diabetes. It is not to be used with type 1 diabetics. Doctors are hopeful that the new once a day medication will help patients gain better management over their diabetes. It is a lot easier to take one pill a day then four pills a day.